The prognosis of elderly patients with hepatocellular carcinoma: A multi‐center 19‐year experience in Japan

The prognosis of elderly patients with hepatocellular carcinoma: A multi‐center 19‐year experience in Japan

Abstract Aims This retrospective study compared the survival between elderly and non‐elderly patients. Methods A total of 5545 treatment‐naive patients with hepatocellular carcinoma (HCC) who visited 7 different hospitals from January 2000 to December 2018 were included. Patients ≥80 years old were...

Full description

Bibliographic Details
Main Authors: Takeshi Hatanaka, Satoru Kakizaki, Atsushi Hiraoka, Kazuya Kariyama, Kunihiko Tsuji, Toru Ishikawa, Hidenori Toyoda, Satoshi Yasuda, Atsushi Naganuma, Toshifumi Tada, Koichi Takaguchi, Akemi Tsutsui, Ei Itobayashi, Noritomo Shimada, Hiroshi Shibata, Takaaki Tanaka, Takuya Nagano, Michitaka Imai, Shinichiro Nakamura, Kazuhiro Nouso, Hisashi Kosaka, Masaki Kaibori, Takashi Kumada, Real‐life Practice Experts for HCC (RELPEC) Study Group
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Cancer Medicine
Subjects:
albumin‐bilirubin grade
curative treatment
hepatocellular carcinoma
liver‐related death
personalized treatment
Online Access:https://doi.org/10.1002/cam4.4850

Internet

https://doi.org/10.1002/cam4.4850

Similar Items